Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries - Wikidata - awgldk - TriplyDB

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

http://www.wikidata.org/entity/Q28187951

about

sameAs

Acute coronary disease Athero-Inflammation: Therapeutic approach Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors Current perspectives in NSAID-induced gastropathy Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1 Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796 Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?Vascular biology of eicosanoids and atherogenesis Aspirin modulates innate inflammatory response and inhibits the entry of Trypanosoma cruzi in mouse peritoneal macrophages.Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.The biology behind the atherothrombotic effects of cigarette smoke.Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit Relationship between cyclooxygenase-2 inhibition and thrombogenesis.Antagonism of thromboxane receptors by diclofenac and lumiracoxib Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation.Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe?Cyclooxygenase products and atherosclerosis Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse.Proof-of-Concept Studies for Marker-Based Ultrasound Doppler Analysis of Microvascular Anastomoses in a Modified Large Animal Model.Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis.Pathophysiology of cyclooxygenases in cardiovascular homeostasis.Adiponectin and hypertension.Celecoxib for the treatment of atherosclerosis.Anti-platelet therapy in small animal medicine.Transmission pathways and mediators as the basis for clinical pharmacology of pain.Participation of COX-1 and COX-2 in the contractile effect of phenylephrine in prepubescent and old rats.Non-steroidal anti-inflammatory drugs attenuate the vascular responses in aging metabolic syndrome rats.Cyclo-oxygenase-2 inhibition and exacerbation of myocardial dysfunction--protection with nitric oxide?Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses.Renal and cardiovascular characterization of COX-2 knockdown mice.Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouse.Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation.The effects of cyclosporine on platelet function and cyclooxygenase expression in normal dogs.

P2860

Q24793068-B0C162DC-545A-4060-A01C-E100AE7FDCFA Q24796005-B9D1F278-F2C5-4211-A2D5-89F018B37BDC Q26827673-3397AB71-3089-4CE6-8999-BE0C5A49B291 Q27658412-E5968792-E77B-47A7-BC62-637838F8266E Q28192589-4DECF059-52C8-4DBB-8B30-C67E0A3334FF Q28193385-915E03B8-D3F8-4922-A418-D1A8BC5FA399 Q28198746-AC8A821A-6D5D-4366-9433-331D80AB24A9 Q28259045-88A95F6D-D258-4842-B1EF-A9BEC7FA092E Q33873763-1EFDAA84-5367-494A-8970-E746488D32E5 Q34245387-5896EE86-165B-4048-B856-538FBA724BEB Q34326163-C14CF5BB-126B-457C-B882-F894962B7D63 Q34601733-2979DD02-2041-4631-AB1D-03EB05AB8D5B Q34636574-A8E38E23-735C-4912-9D19-68D790E6A460 Q35029268-B4B0627C-5D84-4EEB-902C-90B9372E2EB8 Q35287418-76529F65-CF00-4A31-9529-9EC19BF18088 Q35750211-8C288719-FCEA-4F60-8678-569B42ED1E25 Q36358638-91E20E41-2A36-416A-B06F-8CB96F6E5727 Q36673018-AD781986-DB78-403E-A4D8-08209DB00357 Q36802113-F4347E47-7956-4FC3-B7C2-715DFA670F99 Q36869571-E8B4C552-342A-4C19-8551-0E7574C09A22 Q37071164-3D1BA894-7B48-431D-B757-3A867A797559 Q37162532-4B34CB2B-448D-4522-858E-DE37502BB713 Q37191064-195601E8-A50D-453E-8ECD-E9CEA1036340 Q37315920-268BBDCB-96CC-4C6E-A2AD-B398AB88877C Q37736991-985CCA2D-E128-499C-8BAD-95BDED78F802 Q37798714-642F0C09-593D-4177-93F7-8CA394EC2F9E Q38759585-41CBF6CB-7C10-422C-9C38-3BD290E6ECF4 Q38770733-34D85581-2951-4FC1-B1AC-E6A83299BA3F Q38870522-8DE1C7FE-A89D-4174-9D2D-83AD72544DA3 Q40997761-3B570B01-3086-48DD-9501-6DC3F93058B4 Q42263009-820EF7D9-B36F-4A3E-BC7D-4B345CD368BE Q43263866-AE034795-2D51-4166-8AF1-7F88B382E6DA Q44653192-F5F88A7D-CC0F-49D9-A605-8847590CF774 Q46055913-FF55438D-7BD1-480C-98CE-93AD3FA5CAF4 Q46465718-3EB0BB15-5070-442D-9EEC-06572A0816D2 Q46653969-ADC83FEE-0253-400C-9CDD-7530F9C00D91 Q46962257-87876EAC-D98F-417F-AE45-25BDF5BC0980 Q47966984-5A944713-3518-4300-92C8-D57B81DB038F Q51300207-0BEDCDD1-FA72-4767-9068-DDA6F3FF2342

P2860

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

http://www.wikidata.org/entity/Q28187951

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Effects of selective cyclooxyg ...... is in canine coronary arteries

@ast

Effects of selective cyclooxyg ...... is in canine coronary arteries

@en

Effects of selective cyclooxyg ...... is in canine coronary arteries

@nl

type

label

Effects of selective cyclooxyg ...... is in canine coronary arteries

@ast

Effects of selective cyclooxyg ...... is in canine coronary arteries

@en

Effects of selective cyclooxyg ...... is in canine coronary arteries

@nl

prefLabel

Effects of selective cyclooxyg ...... is in canine coronary arteries

@ast

Effects of selective cyclooxyg ...... is in canine coronary arteries

@en

Effects of selective cyclooxyg ...... is in canine coronary arteries

@nl

P1433

Q28187951-0B1A4BC6-D0B0-4BD5-B283-35B97E060FAA

P1476

Q28187951-6BEDAB40-6DED-40E8-ADCC-C0E43B2E7785

P2093

Q28187951-01CAB362-D3E0-4DBB-82B0-2304BCCB9FDD

Q28187951-32B3F7AB-8B86-4502-B5B8-EA8023CA2A97

Q28187951-4D1AEAD7-70EE-4651-913E-A78102F6FA00

Q28187951-57BC4AF8-AB80-4339-B0FA-29BC49D435F4

Q28187951-5C3B9498-3545-4B11-B4F2-BCDEF8CFEC16

Q28187951-996E4B56-2411-44D7-B0AC-72883B5A84A5

Q28187951-D48B140B-A2CA-4720-B3B1-D86432DE888F

Q28187951-FCFEB2A7-8A47-4333-9DBF-E2BE38C23F92

P304

Q28187951-3AABF2A2-0C8A-47F2-882E-68ED354BFADE

P31

Q28187951-BD576D16-C326-42A3-ACC5-74CE327AAFB6

P356

Q28187951-95E2FD15-B85C-4401-B2AB-E98800CB8AE4

P407

Q28187951-A4850B66-75CE-4597-9463-BBB2F9A41AE5

P433

Q28187951-1ED8D961-CA57-45A1-930D-C91A3B7E6DEE

P478

Q28187951-CB8CAE19-17B9-4ECD-98C6-24AC1EB72C17

P577

Q28187951-84512443-C379-400F-92E4-C3DB548669E7

P5875

Q28187951-ACB12FB3-4E8C-41EF-A562-CC52202865CE

P698

Q28187951-0E091046-D6E8-44A8-BE79-35D3187C381E

P921

Q28187951-2466A5AF-C9BB-4EE7-9530-CB08D5672DE3

P356

P1433

P1476

Effects of selective cyclooxyg ...... is in canine coronary arteries

@en

P2093

A M Park

http://www.w3.org/2001/XMLSchema#string

B R Lucchesi

http://www.w3.org/2001/XMLSchema#string

D E Willens

http://www.w3.org/2001/XMLSchema#string

E M Driscoll

http://www.w3.org/2001/XMLSchema#string

J Huang

http://www.w3.org/2001/XMLSchema#string

J K Hennan

http://www.w3.org/2001/XMLSchema#string

L J Crofford

http://www.w3.org/2001/XMLSchema#string

T D Barrett

http://www.w3.org/2001/XMLSchema#string

P304

820-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HC3301.092790

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11841683

http://www.w3.org/2001/XMLSchema#string

P698

11502709

http://www.w3.org/2001/XMLSchema#string

P921